A. Kisim Et Al. , "Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels," Journal of Cancer Research and Clinical Oncology , vol.138, no.7, pp.1155-1163, 2012
Kisim, A. Et Al. 2012. Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels. Journal of Cancer Research and Clinical Oncology , vol.138, no.7 , 1155-1163.
Kisim, A., ATMACA İLHAN, H., Cakar, B., Karabulut, B., Sezgin, C., Uzunoglu, S., ... Uslu, R.(2012). Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels. Journal of Cancer Research and Clinical Oncology , vol.138, no.7, 1155-1163.
Kisim, Asli Et Al. "Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels," Journal of Cancer Research and Clinical Oncology , vol.138, no.7, 1155-1163, 2012
Kisim, Asli Et Al. "Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels." Journal of Cancer Research and Clinical Oncology , vol.138, no.7, pp.1155-1163, 2012
Kisim, A. Et Al. (2012) . "Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels." Journal of Cancer Research and Clinical Oncology , vol.138, no.7, pp.1155-1163.
@article{article, author={Asli Kisim Et Al. }, title={Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels}, journal={Journal of Cancer Research and Clinical Oncology}, year=2012, pages={1155-1163} }